InsidersTradesSigma
Follow the 대한뉴팜 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 대한뉴팜 has published 46 public disclosures. Market capitalisation: €78bn. The latest transaction was reported on 29 May 2026 (Purchase). Among the most active insiders: 이완진. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 46 declarations
대한뉴팜 是一家在医疗保健和制药领域运营的公司，在 XKRX 交易所上市。该公司专注于药品的开发和营销。